Sleep Medicine

  • Reducing the risks when using benzodiazepines to treat insomnia: A public health approach

    Vania Modesto-Lowe, MD, MPH, Margaret M. Chaplin, MD, Roberto León-Barriera, MD and Lakshit Jain, MD
    • Cleveland Clinic Journal of Medicine May 2024, 91 (5) 293-299;
    • DOI: https://doi.org/10.3949/ccjm.91a.23061

    • The authors review measures for preventing harm before benzodiazepines are prescribed, decreasing harm within 4 weeks after they are prescribed, and limiting harmful effects of long-term prescribing.

  • ‘Guidelines to Practice’ series: Asthma in adults

    Brian F. Mandell, MD, PhD
    • Cleveland Clinic Journal of Medicine July 2021, 88 (7) 365;
    • DOI: https://doi.org/10.3949/ccjm.88b.07021

    • A clinically useful summary, highlighting the practical and newer conceptual aspects of the guidelines.

  • Outpatient management of asthma in adults: A snapshot of the 2020 GINA report

    Kavya Kommaraju, MD and Mani Latifi, MD
    • Cleveland Clinic Journal of Medicine July 2021, 88 (7) 377-380;
    • DOI: https://doi.org/10.3949/ccjm.88a.20167

    • A review of the guidelines, with a focus on what’s new and clinically important.

  • Quetiapine for primary insomnia: Consider the risks

    Vania Modesto-Lowe, MD, MPH, Agata K. Harabasz, MD and Sophia A. Walker, MD
    • Cleveland Clinic Journal of Medicine May 2021, 88 (5) 286-294;
    • DOI: https://doi.org/10.3949/ccjm.88a.20031

    • Its cardiometabolic effects and potential for abuse warrant caution in off-label use.

  • Is regular oxygen supplementation safe for obese postoperative patients?

    Roop Kaw, MD and Anthony G. Doufas, MD, PhD
    • Cleveland Clinic Journal of Medicine December 2020, 87 (12) 723-727;
    • DOI: https://doi.org/10.3949/ccjm.87a.19051

    • Caution for some, but no evidence to support withholding it altogether.

  • Beyond depression: Other uses for tricyclic antidepressants

    Joanne Schneider, DNP, RN, CNP, Mary Patterson, CNP and Xavier F. Jimenez, MD, MA
    • Cleveland Clinic Journal of Medicine December 2019, 86 (12) 807-814;
    • DOI: https://doi.org/10.3949/ccjm.86a.19005

    • The pharmacology of these drugs, their potential uses in conditions other than depression, and safety considerations.

  • SEEDS for success: Lifestyle management in migraine

    Jennifer Robblee, MD, MSc and Amaal J. Starling, MD
    • Cleveland Clinic Journal of Medicine November 2019, 86 (11) 741-749;
    • DOI: https://doi.org/10.3949/ccjm.86a.19009

    • Lifestyle counseling can be based on the mnemonic SEEDS: sleep, exercise, eat, diary, and stress.

  • Should I evaluate my patient with atrial fibrillation for sleep apnea?

    Mirna B. Ayache, MD, MPH, Reena Mehra, MD, MS, FCCP, FAASM and Kenneth A. Mayuga, MD, FACC, FHRS
    • Cleveland Clinic Journal of Medicine November 2019, 86 (11) 709-712;
    • DOI: https://doi.org/10.3949/ccjm.86a.19033

    • Yes. The prevalence of sleep apnea is high in patients with atrial fibrillation, and vice versa.

  • A link between A-fib and sleep apnea is no surprise, but why?

    Brian F. Mandell, MD, PhD
    • Cleveland Clinic Journal of Medicine November 2019, 86 (11) 706-707;
    • DOI: https://doi.org/10.3949/ccjm.86b.11019

    • The two conditions commonly coexist, and treating the sleep apnea results in better rhythm-directed outcomes in the A-fib.

  • What are the risks to inpatients during hospital construction or renovation?

    Amjad Kanj, MD, Yuqing Gao, MD and Ayman O. Soubani, MD
    • Cleveland Clinic Journal of Medicine October 2019, 86 (10) 650-652;
    • DOI: https://doi.org/10.3949/ccjm.86a.19008

    • Risks include mold infection, Legionnaires disease, sleep deprivation, exacerbation of lung disease, and physical injury.

Previous
Next